5.31
+0.05(+0.95%)
Currency In USD
| Previous Close | 5.26 |
| Open | 5.25 |
| Day High | 5.52 |
| Day Low | 5.23 |
| 52-Week High | 14.6 |
| 52-Week Low | 3.79 |
| Volume | 529,470 |
| Average Volume | 757,978 |
| Market Cap | 291.52M |
| PE | -8.05 |
| EPS | -0.66 |
| Moving Average 50 Days | 5.49 |
| Moving Average 200 Days | 6.25 |
| Change | 0.05 |
If you invested $1000 in Candel Therapeutics, Inc. (CADL) since IPO date, it would be worth $758.57 as of October 24, 2025 at a share price of $5.31. Whereas If you bought $1000 worth of Candel Therapeutics, Inc. (CADL) shares 3 years ago, it would be worth $2,794.74 as of October 24, 2025 at a share price of $5.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board
GlobeNewswire Inc.
Oct 16, 2025 12:05 PM GMT
NEEDHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
GlobeNewswire Inc.
Oct 14, 2025 12:10 PM GMT
$50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company’s financial position; enables initiation of phase 3 clinical trial of CAN-2409 in non-small cell lung cancer (NSCLC)Provides non-dilutive capital and
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
GlobeNewswire Inc.
Oct 14, 2025 12:05 PM GMT
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer